Pharma exporters seek rollback of rule banning export of India-only drugs

A new regulation by India's drug authority, restricting the export of pharmaceuticals labeled "For sale in India only," is causing significant losses to exporters, estimated at $500 million, and limiting access to affordable medicines for patients abroad.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/kKhdya9
via IFTTT